Literature DB >> 17377594

Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia.

M Chowdhury, K Mihara, S Yasunaga, M Ohtaki, Y Takihara, A Kimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17377594     DOI： 10.1038/sj.leu.2404623

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  36 in total

1.  Role of Polycomb-group genes in sustaining activities of normal and malignant stem cells.

Authors:  Yoshihiro Takihara
Journal:  Int J Hematol       Date:  2007-11-30       Impact factor: 2.490

2.  Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.

Authors:  Aaron Cooper; John van Doorninck; Lingyun Ji; Darren Russell; Marc Ladanyi; Hiroyuki Shimada; Mark Krailo; Richard B Womer; Jessie Hao-ru Hsu; Dafydd Thomas; Timothy J Triche; Richard Sposto; Elizabeth R Lawlor
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

Review 3.  The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.

Authors:  Emi Takamatsu-Ichihara; Issay Kitabayashi
Journal:  Int J Hematol       Date:  2016-04-16       Impact factor: 2.490

4.  High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma.

Authors:  Qilai Long; Li Liu; Yu Xia; Qi Bai; Jiajun Wang; Jiejie Xu; Jianming Guo
Journal:  Tumour Biol       Date:  2015-05-14

Review 5.  Context-dependent actions of Polycomb repressors in cancer.

Authors:  M Koppens; M van Lohuizen
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

6.  Loss of expression of both miR-15/16 loci in CML transition to blast crisis.

Authors:  Francesca Lovat; Pierluigi Gasparini; Giovanni Nigita; Karilyn Larkin; John C Byrd; Mark D Minden; Michael Andreeff; Bing Z Carter; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 7.  Epigenetics in the hematologic malignancies.

Authors:  Chun Yew Fong; Jessica Morison; Mark A Dawson
Journal:  Haematologica       Date:  2014-12       Impact factor: 9.941

8.  Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma.

Authors:  Hui Wang; Ke Pan; Hua-kun Zhang; De-sheng Weng; Jun Zhou; Jian-jun Li; Wei Huang; Hai-feng Song; Min-shan Chen; Jian-chuan Xia
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-05       Impact factor: 4.553

9.  Utility of BMI-1 and NANOG expression levels in survival prediction of pediatric acute lymphoblastic leukemia.

Authors:  Sara Abdel-Khalek; Layla M Saleh; Sherin Abdel-Aziz; Ayman Hyder; Hasan Abdel-Ghaffar
Journal:  Hematol Transfus Cell Ther       Date:  2020-03-13

10.  Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal.

Authors:  Mairi S Shepherd; Juan Li; Nicola K Wilson; Caroline A Oedekoven; Jiangbing Li; Miriam Belmonte; Juergen Fink; Janine C M Prick; Dean C Pask; Tina L Hamilton; Dirk Loeffler; Anjana Rao; Timm Schröder; Berthold Göttgens; Anthony R Green; David G Kent
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.